Tech Company Financing Transactions
Neuraltus Pharmaceuticals Funding Round
Private investors participated in a $14.9 million funding round for Neuraltus Pharmaceuticals. The round was announced on 5/25/2016.
Transaction Overview
Company Name
Announced On
5/25/2016
Transaction Type
Venture Equity
Amount
$14,938,357
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2479 E. Bayshore Rd. 220
Palo Alto, CA 94303
USA
Palo Alto, CA 94303
USA
Phone
Website
Email Address
Overview
Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Whelan
Chief Medical Officer
Gil Block
Chief Scientific Officer
Michael McGrath
Browse more venture capital transactions:
Prev: 5/25/2016: Bloomz venture capital transaction
Next: 5/25/2016: buddybuild venture capital transaction
Share this article
News on VC Transactions
We report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs